Variant Identification in BARD1, PRDM9, RCC1, and RECQL in Patients with Ovarian Cancer by Targeted Next-generation Sequencing of DNA Pools.
Malwina SuszynskaMagdalena RatajskaPaulina Galka-MarciniakAleksandra RyszkowskaDariusz WydraJaroslaw DebniakAnna JasiakBartosz WasagCezary CybulskiKozłowski PiotrPublished in: Cancer prevention research (Philadelphia, Pa.) (2022)
BARD1, PRDM9, RCC1, and RECQL are not high/moderate-risk ovarian cancer susceptibility genes. Pooled sequencing is a reliable and cost-effective method to detect rare variants in candidate genes.